Clinical Trials
CHRISTINE E. LYNN WOMEN’S HEALTH & WELLNESS RESEARCH

Click here to download a printable copy of this information.

BREAST CANCER

DiagnosisInvestigator/SponsorProtocol title & PurposeEligibility
High Risk Breast CancerKathy Schilling, MD / Ellman FoundationDynamic Contrast Enhanced MRI and Contrast Enhanced Spectral Mammography in the Diagnosis of Breast Cancer the Women of High Risk: A Comparison Study

  • Women age 25 or older
  • Women assessed to have a greater than 20% Lifetime risk of breast cancer on the basis of one of the following: BRCA positive, family history consistent with Hereditary Breast and Ovarian Cancer with negative BRCA test result in either an affected family member or if none available, negative in the subject, patient’s with other suspected familial syndrome or LCIS history or history of Hodgkin’s Disease treated with mantle radiation therapy, personal history of breast cancer treated with either breast conservation or mastectomy.
  • No contraindications to gadolinium or MRI (renal failure or GFR<30 ml/min, pacemaker, uncontrollable claustrophobia, weight >300 pounds, unable to tolerate prone position).
  • No allergy to iodine.

BREAST IMAGING

Skip Navigation Links.